ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Love and Support: An 80-Year-Old Mother's Journey with Aortic Stenosis

By: NewsUSA

(NewsUSA) - All her life, Darian Tymes has been a high-energy woman with a positive spirit and a can-do attitude. When she started losing her breath and feeling fatigued simply moving from room to room, 80-year-old Darian and her children knew that something was wrong.

With the support of her daughters, Darian made frequent visits to a local cardiologist to try to find the cause of her breathlessness. Unable to make a full diagnosis, her cardiologist referred her to a specialist, Mustafa Ahmed, M.D.

“When she came into my office the first time, I knew she was in trouble,” said Dr. Ahmed. “You knew something was wrong because she is someone who is normally extraordinary, active and independent, and at that moment I saw her quality of life was being impacted.”

After running tests, Dr. Ahmed was able to diagnose Darian with severe aortic stenosis (SAS), a progressive disease that occurs when the heart’s aortic valve narrows, preventing blood from flowing normally. Symptoms of SAS can include chest pain, rapid heart rhythm, trouble breathing and shortness of breath, lightheadedness, difficulty walking short distances, swollen ankles or feet, and difficulty sleeping or needing to sleep sitting up.

Sometimes, it can be easy to confuse these symptoms with general aging, which makes visits to a cardiologist even more important. It is better to get it checked out and be wrong than to have an undiagnosed and untreated heart condition.

SAS affects women differently than men. Generally, women live longer than men, but once women develop SAS, they suffer higher mortality, even when a man and woman are the same age1. After developing symptoms, and if left untreated, the average patient survival is two years without treatment2. Additionally, studies in the US found Black patients with SAS are less likely to receive life-saving treatment compared to other Americans, putting someone like Darian at greater risk3.


Darian's Story

 

 

 

 

 

 

 

 

 

After receiving a diagnosis, Darian and her family knew they needed to take action. While Darian was relieved to finally have an answer to her health concerns, she was understandably nervous about what treatment would entail. Years prior, Darian underwent open-heart surgery, an experience that took a toll on her body and she did not want to endure again. Luckily, Darian was told by her doctor that this kind of major surgery was no longer the norm, and she was an ideal candidate for a minimally invasive alternative.

“I asked them, ‘Are they going to cut my chest open again?’ They said, ‘No. It’s a simple, minimally invasive procedure.’ After they told me how they were going to do it I said, ‘Okay I’m ready.’”

Darian received a transcatheter valve replacement (TAVR) procedure. TAVR is a minimally invasive procedure to replace a diseased aortic valve with a new, artificial valve. Instead of traditional open-heart surgery, TAVR uses a thin, flexible tube called a catheter. The doctor guides the catheter to a patient’s heart through blood vessels which can be accessed through the groin, thigh, stomach, chest, neck, or collarbone. The new valve, which is folded inside the catheter, is then placed securely within the existing valve. With no need for surgery, TAVR means a shorter recovery time and less discomfort, helping patients get back to everyday life more quickly.  Because women’s hearts tend to have smaller valves when compared to men, TAVR is a very important treatment option for women.

Darian underwent this procedure with the tested and proven effective EvolutTM TAVR System from Medtronic to treat her aortic stenosis.

A recent study called the SMART Trial, published in the New England Journal of Medicine, compared the system to other valves on the market and found that the new Evolut valve worked very well and demonstrated excellent patient outcomes, especially in women4. These new insights are helping women and their doctors make the decision on what treatment option works best for them.

“Before the procedure, I was not nervous. I was not scared, I was completely relaxed.”

After taking action and undergoing her TAVR procedure, Darian is able to relax once again - if she wants to! No longer feeling shortness of breath and dizziness from walking from room to room, Darian is up and moving, living life the way she always has lived it. “I can walk, I can cook, I can dance, drive…I can do it all myself and I love it. Now at 83 years old, after raising five children, six grandchildren, and working hard, I am entitled to enjoy the rest of my life.”

Seeing Darian back on her feet and on the move has been a joy to her family, and they say that now they even have a hard time keeping up with her.

For more information on aortic stenosis, visit: MyInteractiveASJourney.com

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

1Am Heart Assoc. 2021;10:e018816. DOI: 10.1161/JAHA.120.018816,

2 Lester SJ, Heilbron B, Gin K, Dodek A, Jue J. The natural history and rate of progression of aortic stenosis. Chest. April 1998;113(4):1109-1114

3Alkhouli, M et al. J Am Coll Cardiol Inntv. 2019 May. 12 (10) 936-948

4SMART Trial

Recent Quotes

View More
Symbol Price Change (%)
AMZN  249.32
-4.68 (-1.84%)
AAPL  270.04
+0.99 (0.37%)
AMD  250.05
-9.60 (-3.70%)
BAC  53.54
-0.02 (-0.04%)
GOOG  278.06
-6.06 (-2.13%)
META  627.32
-10.39 (-1.63%)
MSFT  514.33
-2.70 (-0.52%)
NVDA  198.69
-8.19 (-3.96%)
ORCL  248.17
-9.68 (-3.75%)
TSLA  444.26
-24.11 (-5.15%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.